<DOC>
	<DOCNO>NCT00828906</DOCNO>
	<brief_summary>To evaluate effectiveness DuoTrav Eye Drops gain maintain control target Intraocular Pressures ( tIOP ) patient diagnose , treat , open-angle glaucoma ( OAG ) ocular hypertension ( OH ) .</brief_summary>
	<brief_title>DuoTravÂ® Eye Drops As Replacement Therapy Program</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Patients OAG OH single agent therapy provide insufficient intraocular pressure reduction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>IOP</keyword>
	<keyword>DuoTrav</keyword>
</DOC>